Clinical study of Four Hair Oils in Hair loss in females

A Randomized, Single blind, Multi-center, Prospective, Comparative Clinical Study to evaluate efficacy and safety of Four Hair Oil formulations in mild to moderate Hair loss in females - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013899

Enrollment

200

Registered

2018-05-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Mild to moderate Hair loss in females

Interventions

Intervention1: KKPO4 Oil: It contains Emblica officinalis,Bacopa monnieri, Eclipta alba, Terminalia belerica, Tribulus terrestris, Terminalia chebula, Nardostachys jatamansi,Hibiscus rosasinensis,Zizy

Eligibility

Inclusion criteria

Inclusion criteria: 1.Female subjects between the age group of 18- 45 years both inclusive. 2.Subjects suffering from mild to moderate hair loss (40-140 Hair by Comb test and Finger Test). 3.Subjects who are infrequent hair oil users. 4.Subjects who are willing to give informed consent and ready to comply with the protocol. 5.Subjects who are ready to provide regular follow ups till the completion of the study

Exclusion criteria

Exclusion criteria: 1.Subjects with severe Hair fall due to any clinically significant disorder/s like anemia, thyroid disorders etc. 2.Subject with severe dermatological disorders of the scalp that might interfere with the study evaluation. 3.Subjects with recent disease history like malaria, typhoid, jaundice and scalp diseases and subjects who in the opinion of the investigator are not eligible for enrollment in the clinical study. 4.Subjects who have regularly used anti-hair fall treatment with hair oil over the last 6 months. 5. Subjects who have previously undergone hair transplantation procedures. 6.Subjects on systemic steroids for more than 14 days within 2 months prior to enrollment. 7.Subjects on immunosuppressive drugs. 8. Known cases of Hypersensitivity to hair oil contents. 9.Subjects who have participated in any other clinical study since last 3 months. 10.Subjects who are reported pregnant/planning a pregnancy or lactating. 11. Menopausal Women.

Design outcomes

Primary

Measure	Time frame
1. Assessment of hair fall in four different hair oils by running finger test over a period of 2 months. 2. Assessment of hair breakage in four different hair oils by comb test over a period of 2 months. Timepoint: Day -3, Day 0, Day 15, Day 30, Day 45, Day 60.	—

Secondary

Measure	Time frame
1. Assessments of hair fall by Hair Pull test. 2. Assessment of hair growth by comparing against standard non-users. 3. Assessment of effect of four different hair oils on dandruff. 4. Assessment of effect of four different hair oils on quality of hair based on subject questionnaire. 5. Global assessment of overall change in hair loss by the physician and subject. 6. Assessment of safety by observing episodes, severity and duration of any allergic reactions & adverse events. Timepoint: Day -3, Day 0, Day 15, Day 30, Day 45, Day 60.	—

Measure

Time frame

1. Assessments of hair fall by Hair Pull test. 2. Assessment of hair growth by comparing against standard non-users. 3. Assessment of effect of four different hair oils on dandruff. 4. Assessment of effect of four different hair oils on quality of hair based on subject questionnaire. 5. Global assessment of overall change in hair loss by the physician and subject. 6. Assessment of safety by observing episodes, severity and duration of any allergic reactions & adverse events. Timepoint: Day -3, Day 0, Day 15, Day 30, Day 45, Day 60.

—

Countries

India

Contacts

Public ContactVandana Bade

Target Institute of Medical Education and Research

targetinstitute@yahoo.com9322522252

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026